Standigm reveals novel drug discovering services using new AI technology

Published: 2017-11-10 14:26:47

Updated: 2017-11-10 14:26:47

A novel drug discovering company based on artificial intelligence ‘Standigm(CEO Jin-Han Kim)’ announced the company selected as the next-generation pharmaceutical and biotechnology company at the ‘23^th Bio-Europe,’ an international partnering conference in Berlin between the 6^th and 8^th was able to represent its cutting-edge technological result.

Standigm is a technology company that improves ...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.